Trial of CF101 to Treat Patients With Psoriasis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

293

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

May 31, 2015

Conditions
Plaque Psoriasis
Interventions
DRUG

CF101

orally q12h

DRUG

Placebo

orally q12h

Trial Locations (18)

1407

"MHAT Tokuda hospital Sofia", Sofia

1463

"DCC Fokus-5-MIOC, EOOD", Sofia

1606

Military Medical Acdemy (MMA), Sofia

6003

Multiprofile Hospital for Active Ttreatment, Stara Zagora

31096

Rambam Medical Center, Haifa

49100

Rabin Medical Center, Petah Tikva

900622

Spitalul Clinic Judetean de Urgenta Constanta, Constanța

Unknown

Mount Sinai School of Medicine, New York

City Center for Skin and Venereal Disease, Sofia

Haemek Medical Center, Afula

Centrul Medical Euromed, Bucharest

Spitalul Clinic Dermato-Venerice, Bucharest

Emergency County Clinical Hospital, Cluj-Napoca

County Clinical Emergency Hospital, Sibiu

5800,

"UMHAT G.stranski", Pleven

1632,

"MHAT Doverie", Sofia

9010,

MHAT Varna at MMA Sofia, Varna

700368,

Spit Clinic Judetean de Urgenta Sf Spiridon Iasi, Iași

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Can-Fite BioPharma

INDUSTRY